SCMP Tech5/13/2026BusinessChina
METiS TechBio debuts on Hong Kong stock market with 173% surge
AI-driven drug design start-up compares itself to SpaceX for the pharmaceutical industry
Quick Look
METiS TechBio's shares surged 173% on their Hong Kong debut, with the AI-driven drug design start-up raising HK$2.11 billion from its initial public offering
AI-generated summary
Font size
METiS TechBio's shares surged 173% on their Hong Kong debut, with the AI-driven drug design start-up raising HK$2.11 billion from its initial public offering
Related Topics
This article was originally published by SCMP Tech.
